Author:
Pak Y. Anne,Posada Maria M.,Bacon James,Long Amanda,Annes William,Witcher Jennifer,Mitchell Malcolm,Tirona Rommel G.,Hall Stephen D.,Hillgren Kathleen M.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology
Reference34 articles.
1. Pak YA, Long AJ, Annes WF, Witcher JW, Knadler MP, Ayan-Oshodi MA, Mitchell MI, Leese P, Hillgren KM. In vitro and clinical evaluations of the drug-drug interaction potential of a metabotropic glutamate 2/3 receptor agonist prodrug with intestinal peptide transporter 1. Drug Metab Dispos. 2017;45(2):137–44.
2. Moulton RD, Ruterbories KJ, Bedwell DW, Mohutsky MA. In vitro characterization of the bioconversion of pomaglumetad methionil, a novel metabotropic glutamate 2/3 receptor agonist peptide prodrug. Drug Metab Dispos. 2015;43(5):756–61.
3. Annes WF, Long A, Witcher JW, Ayan-Oshodi MA, Knadler MP, Zhang W, Mitchell MI, Cornelissen K, Hall SD. Relative contributions of presystemic and systemic peptidases to oral exposure of a novel metabotropic glutamate 2/3 receptor agonist (LY404039) after oral administration of prodrug pomaglumetad methionil (LY2140023). J Pharm Sci. 2015;104(1):207–14.
4. Witcher JLA, Seger ME, Wessels AM, Annes WF, Knadler M, Marbury TC, Ayan-Oshodi M. In Effects of renal impairment on LY2140023 and LY404039 pharmacokinetics, Clinical Pharmacology & Therapeutics, 2013; pp S100-S101.
5. Hillgren KM, Keppler D, Zur AA, Giacomini KM, Stieger B, Cass CE, Zhang L. International Transporter, C., Emerging transporters of clinical importance: an update from the International Transporter Consortium. Clin Pharmacol Ther 2013, 94 (1), 52-63.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献